38 Liraglutide Liraglutide is a 31 aa-long synthetic peptide drug attached to 16 carbon fatty acids (MW: 3751 g/mol) (Figure 1D)
At the three-month mark, patients taking Mounjaro lost 5.9% of their weight, compared with 3.6% for those on Ozempic, the study showed At six months, people taking Mounjaro shed 10.1% of their weight, while patients on Ozempic lost 5.9% Eli Lillys Mounjaro patients were significantly more likely to achieve 5%, 10% and 15% weight loss and experience larger reductions to weight at three, six and 12 months, than those who took Ozempic, the report concluded
Honnold has led numerous programs and seminars to educate other plaintiffs attorneys on the semaglutide/weight loss litigation on key topics including medical issues, adverse event reports for the products, case vetting, legal issues (preemption), and potential new defendants
doi: 10.1186/ar1784 207 DerryHMFagundesCPAndridgeRGlaserRMalarkeyWBKiecolt-GlaserJK